Reversal of the anticoagulant effect of direct thrombin inhibitor dabigatran etexilate in acute ischemic stroke and intracranial hemorrhage using idarucizumab – A case study

Autor:	Amod Tilak, Sonesh Kalra, Nasli R Ichaporia, Ashutosh N Shetty
Rok vydání:	2019
Předmět:	Fibrillation medicine.medical_specialty business.industry Atrial fibrillation Idarucizumab medicine.disease Dabigatran Direct thrombin inhibitor Internal medicine medicine Cardiology cardiovascular diseases Neurosurgery medicine.symptom business Acute ischemic stroke Stroke medicine.drug
Zdroj:	IP Indian Journal of Neurosciences. 5:176-180
ISSN:	2581-916X 2581-8236
DOI:	10.18231/j.ijn.2019.028
Popis:	The non-Vitamin K oral anticoagulants (NOACs) help prevent stroke in patients of atrial fibrillation. However, management of patients on NOACs in emergency situations is a challenging prospect. Idarucizumab is approved globally as well as in India as the specific reversal agent for dabigatran. We report two cases with successful reversal using Idarucizumab in acute ischemic stroke and intracranial hemorrhage. Keywords: Atrial fibrillation, Bleeding, India, Stroke.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3d2efb4ef36e6871b258c686904302a1 https://doi.org/10.18231/j.ijn.2019.028 Zobrazit plný text záznamu